Therapeutic composition for combatting AIDS

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 45, 514 49, 514110, 514274, 514644, A61K 31505, A61K 3170, A61K 3166, A61K 3113

Patent

active

050514253

ABSTRACT:
A therapeutic composition for combatting acquired immune deficiency syndrome (AIDS) comprising: (A) a pharmaceutically effective amount of at least one carcinostatic agent selected from alkylating agents and antimetabolites and (B) a pharmaceutically acceptable carrier.

REFERENCES:
Chemical Abstracts, 92: 135417m (1980) as define in 10th Collective Index, p. 54712cs (vol. 1).
Chemical Abstracts, 93: 13083z (1980).
Balzarini et al., Mol. Pharmacol., 32:162-167 (1987).
Robins, Pharmaceutical Res., 1:11-17 (1984).
Gill et al., Proc. Annu. Meet. Am. Soc. Clin. Oncol., 5:5 (1986) (Abstract).
Gill et al., Third International Conference on Malignant Lymphoma (Jun. 10-13, 1987) (Abstract).
Gill et al., Proceedings of Asco, 5:5 (1986) (Abstract).
Gill et al., J. Clin. Oncol., 5:1322-1328 (1987).
Harada et al., Virol., 146:272-281 (1985).
Sarin et al., Nato Asi Ser. Ser A, 120:329-342 (1986).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic composition for combatting AIDS does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic composition for combatting AIDS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic composition for combatting AIDS will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1696866

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.